Clinical Trial Update: Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of polyglutamate paclitaxel in combination with carboplatin for ovarian epithelial, fallopian tube, and primary peritoneal cancers; the trial has …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Paclitaxel polyglutamate (paclitaxel polyglutamate)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Fallopian Tube Carcinoma, Malignant Ovarian Mixed Epithelial Tumor | Phase 1 | Status: COMPLETED